IRCT2016070428786N1
Completed
Phase 1
Phase I Clinical Trial to Examine the Safety of Transplantation of Mesenchymal Stem Cells in New-onset Type 1 Diabetes Patients
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Diabetes.
- Sponsor
- Royan Institute
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Type 1 diabetes detection in less than 6 weeks; diabetes diagnosis according to American Diabetes Association; Presence of Antibodies against pancreatic beta cells; Both Sexes; Age: 8\-40 years; Fasting C\-peptide \= 0\.3 ng/ml
Exclusion Criteria
- •Pregnancy or breastfeeding; Cancer; Any acute or severe disease (According to physicians diagnosis: such as cardiac, pulmonary, hepatic, kidney, mental,… diseases); Positive results for: HIV, HTLV, HBV, HCV, CMV; Immune deficient or hyper aesthesia; History of ketoacidosis
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A phase I clinical trial to study the safety of treatment with Tipifarnib (ZARNESTRA) combined with Bortezomib (VELCADE) in patients with myelodysplastic syndrome (MDS)myelodysplasiamyelodysplastic syndroom10018865NL-OMON30154niversitair Medisch Centrum Sint Radboud18
Recruiting
Phase 1
Phase I study for the efficacy and the safety of the perioperative urinastatin therapy in chest surgical patients with interstitial pneumonia.interstitial pneumonia, lung cancer, metastatic lung tumor, pneumothoraxJPRN-UMIN000003295Tokyo Women's Medical University of Medicine, Department of Surgery I30
Completed
Phase 1
A trial to test the safety of a herbal formulatioCTRI/2018/02/011689SK Biolabs100
Completed
Phase 1
A clinical trial to test the safety of a drugCTRI/2017/11/010540SK Biolabs100
Completed
Phase 1
A trial to test the safety of a drugCTRI/2017/12/010788SK Biolabs100